Ensysce Biosciences Effectiveness Notice Filed
Ticker: ENSC · Form: EFFECT · Filed: Apr 16, 2026 · CIK: 0001716947
Sentiment: neutral
Topics: registration-statement, effectiveness, securities
Related Tickers: ENSY
TL;DR
Ensysce (ENSY) registration statement is now EFFECTIVE as of 4/15/26. Big news for potential stock moves.
AI Summary
Ensysce Biosciences, Inc. filed an EFFECT form on April 16, 2026, indicating the effectiveness of a registration statement. The effectiveness date is April 15, 2026, related to file number 333-294939.
Why It Matters
This filing signifies that a registration statement for Ensysce Biosciences, Inc. has become effective, which is a crucial step for potential stock offerings or other securities transactions.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step that can precede significant financial events, carrying inherent market risks.
Key Numbers
- 2026-04-15 — Effectiveness Date (The date the registration statement became effective.)
- 333-294939 — File Number (The specific registration file number associated with this filing.)
Key Players & Entities
- Ensysce Biosciences, Inc. (company) — Filer
- 0001716947 (company) — CIK Number
- 333-294939 (dollar_amount) — File Number
- 2026-04-16 (date) — Filing Acceptance Date
- 2026-04-15 (date) — Effectiveness Date
FAQ
What type of filing is this?
This is an EFFECT filing, which is a Notice of Effectiveness for a registration statement.
When did this filing become effective?
The registration statement became effective on April 15, 2026.
What is the CIK number for Ensysce Biosciences, Inc.?
The CIK number for Ensysce Biosciences, Inc. is 0001716947.
What is the file number associated with this registration?
The file number is 333-294939.
Where is Ensysce Biosciences, Inc. located?
Ensysce Biosciences, Inc. has its mailing and business address at 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 16, 2026 regarding Ensysce Biosciences, Inc. (ENSC).